Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9RRQ

Human TRPC5 in complex with (-) englerin A, partial occupancy (2EA:2LIP stoichiometry) state 1

This is a non-PDB format compatible entry.
Summary for 9RRQ
Entry DOI10.2210/pdb9rrq/pdb
EMDB information54193
DescriptorShort transient receptor potential channel 5, CALCIUM ION, PHOSPHATIDYLETHANOLAMINE, ... (7 entities in total)
Functional Keywordstrpc5, (-) englerin a, agonist, membrane protein
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight363419.28
Authors
Porav, A.S.,Bon, R.S.,Muench, S. (deposition date: 2025-06-27, release date: 2026-05-13)
Primary citationPorav, S.A.,Ptakova, A.,Bauer, C.C.,Hammond, K.L.R.,Beech, D.J.,Vlachova, V.,Muench, S.P.,Bon, R.S.
(-)-Englerin A binding to human TRPC5 exposes an aromatic interaction network in channel activation.
Nat Commun, 2026
Cited by
PubMed Abstract: TRPC4/5 cation channels are polymodal cellular sensors and emerging drug targets in various human pathologies. The plant natural product (-)-englerin A (EA) is a potent, selective TRPC4/5 agonist that has transformed TRPC4/5 research. However, the structural basis of EA-mediated TRPC4/5 activation has remained elusive, limiting our ability to understand and exploit EA's pharmacology. Here, we present nine high-resolution cryo-EM structures of human TRPC5, representing different states and ligand occupancies, which show that EA occupies a conserved lipid binding site between channel subunits. Conformational changes of residues surrounding this binding site - most notably in the aromatic interaction network around Phe520 - result in rearrangement of the pore helices into a pre-open state. Our structural models are consistent with the effects of mutagenesis on EA's potency, efficacy and activation kinetics, and allow us to rationalise competitive inhibition by other TRPC4/5 modulators as well as EA's selectivity profile within the TRPC family. Our structural insights into the mode-of-action of a widely used TRPC4/5 agonist will underpin fundamental TRPC4/5 research and ongoing drug discovery programmes.
PubMed: 42056091
DOI: 10.1038/s41467-026-71840-y
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.9 Å)
Structure validation

253389

PDB entries from 2026-05-13

PDB statisticsPDBj update infoContact PDBjnumon